Filing Flows › Neogen (NEOG) › Q4 FY26 › vs Q4 FY25
Neogen (NEOG) Q4 FY26 vs Q4 FY25 (year over year)
Neogen's revenue fell $200K (-0.1%) from $226M in Q4 FY25 to $225M in Q4 FY26.
Neogen, Q4 FY26: revenue $225M (-0.1% year over year), operating margin 1.4%, net loss $11.3M, operating cash flow $30.2M. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $225M | $226M | −$200K | -0.1% |
| Income tax benefit | $800K | $19.0M | −$18.2M | -96% |
| Net loss | $11.3M | $612M | −$601M | -98% |
| Costs & expenses | $237M | $857M | −$619M | -72% |
| Operating costs | $222M | $837M | −$614M | -73% |
| Interest & other, net | $15.2M | $20.0M | −$4.8M | -24% |
| Cost of revenue | $118M | $133M | −$15.1M | -11% |
| Research & development | $4.9M | $6.3M | −$1.4M | -22% |
| Sales & marketing | $41.1M | $46.9M | −$5.8M | -12% |
| General & admin | $58.7M | $53.0M | $5.7M | +11% |
| Operating cash sources | $41.5M | $629M | −$587M | -93% |
| Depreciation & amortization | $29.4M | $30.3M | −$900K | -3% |
| Share-based compensation | $3.0M | $4.3M | −$1.3M | -30% |
| Working capital & other | $9.1M | $594M | −$585M | -98% |
| Net loss absorbed | $11.3M | $612M | −$601M | -98% |
| Operating cash flow | $30.2M | $16.4M | $13.8M | +84% |
Questions
How much did Neogen's revenue grow year over year in Q4 FY26?
Neogen's revenue fell $200K (-0.1%) from $226M in Q4 FY25 to $225M in Q4 FY26.